A public health approach to global management of hypertension.
作者信息
Angell Sonia Y, De Cock Kevin M, Frieden Thomas R
机构信息
Centers for Disease Control and Prevention, Atlanta, GA, USA.
Centers for Disease Control and Prevention, Atlanta, GA, USA.
出版信息
Lancet. 2015 Feb 28;385(9970):825-7. doi: 10.1016/S0140-6736(14)62256-X.
Abstract
摘要
相似文献
1
A public health approach to global management of hypertension.一种全球高血压管理的公共卫生方法。
Lancet. 2015 Feb 28;385(9970):825-7. doi: 10.1016/S0140-6736(14)62256-X.
2
Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.发展中国家心血管疾病和高血压药物的可及性：基本药物清单、价格、可获得性及可负担性分析
J Am Heart Assoc. 2020 May 5;9(9):e015302. doi: 10.1161/JAHA.119.015302. Epub 2020 Apr 25.
3
Generic heart drugs as good as brand names. "You get what you pay for" doesn't apply to prescription drugs.通用心脏药物与名牌药物效果相同。“一分钱一分货”不适用于处方药。
Harv Heart Lett. 2009 Feb;19(6):3.
4
Antihypertensive treatment - navigating between cost, compliance and complications.抗高血压治疗——在成本、依从性和并发症之间寻求平衡
Swiss Med Wkly. 2013 Oct 25;143:w13857. doi: 10.4414/smw.2013.13857. eCollection 2013.
5
Substandard drugs among five common antihypertensive generic medications: an analysis from 10 African countries.五种常见降压仿制药中的劣药：来自 10 个非洲国家的分析。
J Hypertens. 2018 Feb;36(2):395-401. doi: 10.1097/HJH.0000000000001560.
6
Anti-hypertensive medication access and affordability and their association with blood pressure control at a teaching hospital in Ghana.加纳一所教学医院的降压药物可及性和可负担性及其与血压控制的关系。
Pan Afr Med J. 2021 Jul 8;39:184. doi: 10.11604/pamj.2021.39.184.27977. eCollection 2021.
7
Access to Antihypertensive Drugs in China.中国的抗高血压药物可及性。
Circulation. 2018 Oct 23;138(17):1777-1779. doi: 10.1161/CIRCULATIONAHA.118.033360.
8
[Generic drugs and the consumption trends of antihypertensives in Morocco].[摩洛哥的仿制药与抗高血压药物消费趋势]
Therapie. 2013 Sep-Oct;68(5):303-12. doi: 10.2515/therapie/2013048. Epub 2013 Nov 14.
9
Medicine prices and availability in the Brazilian Popular Pharmacy Program.巴西平价药品计划中的药品价格和可及性。
Rev Saude Publica. 2010 Aug;44(4):611-9. doi: 10.1590/s0034-89102010005000021. Epub 2010 Jun 25.
10
[Therapy of hypertension. Cost conscious prevention of complications].[高血压治疗。注重成本的并发症预防]
MMW Fortschr Med. 2003 Nov 20;145(47):64.
引用本文的文献
1
Risk variables of heart failure among patients in China: grey relational approach based multi-dimensional assessment study.中国患者心力衰竭的风险变量：基于灰色关联法的多维度评估研究
Diabetol Metab Syndr. 2024 Aug 23;16(1):205. doi: 10.1186/s13098-024-01445-2.
2
Prevalence, trends, and factors associated with hypertensive crisis among Peruvian adults.秘鲁成年人高血压危象的患病率、趋势及相关因素。
Cad Saude Publica. 2024 Feb 19;40(2):e00155123. doi: 10.1590/0102-311XEN155123. eCollection 2024.
3
Assessment of Hypertension Complications and Health Service Use 5 Years After Implementation of a Multicomponent Intervention.评估综合干预实施 5 年后高血压并发症和卫生服务利用情况。
JAMA Netw Open. 2023 May 1;6(5):e2315064. doi: 10.1001/jamanetworkopen.2023.15064.
4
Aqueous extract of reduces blood pressure through inhibiting oxidative stress, inflammation and fibrosis of adventitia in primary hypertension.[提取物名称]的水提取物通过抑制原发性高血压中外膜的氧化应激、炎症和纤维化来降低血压。
Front Pharmacol. 2023 Feb 28;14:1093669. doi: 10.3389/fphar.2023.1093669. eCollection 2023.
5
Comparative efficacy of generic nifedipine versus brand-name amlodipine for hypertension management in Taiwan.比较硝苯地平 generic 与氨氯地平 brand-name 在台湾地区高血压管理中的疗效。
J Clin Hypertens (Greenwich). 2022 Jul;24(7):870-877. doi: 10.1111/jch.14521. Epub 2022 Jun 8.
6
Cardiovascular Disease Mortality and Potential Risk Factor in China: A Multi-Dimensional Assessment by a Grey Relational Approach.中国心血管疾病死亡率及潜在危险因素的灰色关联分析
Int J Public Health. 2022 Apr 29;67:1604599. doi: 10.3389/ijph.2022.1604599. eCollection 2022.
7
Adherence Clubs to Improve Hypertension Management in Nigeria: Clubmeds, a Feasibility Study.在尼日利亚通过依从性俱乐部改善高血压管理：“地中海俱乐部”可行性研究
Glob Heart. 2022 Mar 16;17(1):21. doi: 10.5334/gh.1109. eCollection 2022.
8
The Retail Outlet Health Kiosk Hypertension Trial (ROKHYT): Pilot Results.零售网点健康亭高血压试验（ROKHYT）：初步结果。
Am J Hypertens. 2022 Jan 5;35(1):103-110. doi: 10.1093/ajh/hpab129.
9
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension.全球高血压流行病学、健康负担及有效干预措施
Nat Rev Cardiol. 2021 Nov;18(11):785-802. doi: 10.1038/s41569-021-00559-8. Epub 2021 May 28.
10
Genetic variants of GRK4 influence circadian rhythm of blood pressure and response to candesartan in hypertensive patients.GRK4 基因变异影响高血压患者血压的昼夜节律和坎地沙坦的反应。
Clin Exp Hypertens. 2021 Oct 3;43(7):597-603. doi: 10.1080/10641963.2021.1919357. Epub 2021 Apr 25.
本文引用的文献
1
Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease.组织动态：《2014年世界卫生组织非传染性疾病全球状况报告》；抗击中风和血管疾病的又一里程碑式进展。
Stroke. 2015 May;46(5):e121-2. doi: 10.1161/STROKEAHA.115.008097. Epub 2015 Apr 14.
2
Hypertension: an urgent need for global control and prevention.高血压：全球控制与预防的迫切需求。
Lancet. 2014 May 31;383(9932):1861. doi: 10.1016/S0140-6736(14)60898-9.
3
Control of hypertension with medication: a comparative analysis of national surveys in 20 countries.药物控制高血压：20个国家全国性调查的比较分析
Bull World Health Organ. 2014 Jan 1;92(1):10-19C. doi: 10.2471/BLT.13.121954. Epub 2013 Sep 30.
4
Protocol-based treatment of hypertension: a critical step on the pathway to progress.基于方案的高血压治疗：迈向进展之路的关键一步。
JAMA. 2014 Jan 1;311(1):21-2. doi: 10.1001/jama.2013.282615.
5
Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.高、中、低收入国家城乡社区高血压的患病率、知晓率、治疗率和控制率。
JAMA. 2013 Sep 4;310(9):959-68. doi: 10.1001/jama.2013.184182.
6
Improved blood pressure control associated with a large-scale hypertension program.大规模高血压项目与血压控制改善相关。
JAMA. 2013 Aug 21;310(7):699-705. doi: 10.1001/jama.2013.108769.
7
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.21 个地区 1990-2010 年 67 种致病因素和致病因素群导致的疾病和伤害负担的比较风险评估：全球疾病负担研究 2010 系统分析。
Lancet. 2012 Dec 15;380(9859):2224-60. doi: 10.1016/S0140-6736(12)61766-8.
8
Cohort monitoring of persons with hypertension: an illustrated example from a primary healthcare clinic for Palestine refugees in Jordan.高血压患者的队列监测：来自约旦巴勒斯坦难民营初级保健诊所的实例说明。
Trop Med Int Health. 2012 Sep;17(9):1163-70. doi: 10.1111/j.1365-3156.2012.03048.x. Epub 2012 Jul 29.
9
The first decade of antiretroviral therapy in Africa.抗逆转录病毒治疗在非洲的第一个十年。
Global Health. 2011 Sep 29;7:33. doi: 10.1186/1744-8603-7-33.
10
Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data.心血管药物的可及性、价格和可负担性：使用世界卫生组织/卫生技术评估和采购全球联盟数据对 36 个国家的比较。
BMC Cardiovasc Disord. 2010 Jun 9;10:25. doi: 10.1186/1471-2261-10-25.
Zotero 插件